Literature DB >> 11054774

Family-based study of DRD2 alleles in alcohol and drug dependence.

O Blomqvist1, J Gelernter, H R Kranzler.   

Abstract

Numerous case-control studies have addressed the hypothesis that variant alleles of the dopamine D2 receptor gene (DRD2) increase the liability for alcohol and/or drug dependence, and both positive and negative results have been reported. Because population frequencies of these alleles vary considerably, the conflicting results could be due to population stratification bias. Using the transmission disequilibrium test, the present study examined linkage disequilibrium of alcohol and drug (opioid and/or cocaine) dependence with three DRD2 polymorphic systems: (a) TaqI A, (b) TaqI D, and (c) the functional -141CIns/Del promoter systems. DNA samples were collected from small nuclear families (SNFs), where one or more offspring met DSM-III-R or DSM-IV criteria for alcohol and/or drug dependence. Because positive association between DRD2 alleles and alcohol and/or drug dependence has been reported only in populations of European ancestry, we limited the present study to European Americans (EAs). No evidence for linkage disequilibrium was found for any of the polymorphic systems when examined in relation to any substance dependence, alcohol dependence (with or without drug dependence), or drug dependence (with or without alcohol dependence). These results are consistent with those from a recent family-based study of alcohol dependence. Together, these studies suggest that the conflicting findings from case-control studies of the association between alleles of DRD2 and substance dependence may be attributable to population stratification in some samples.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054774     DOI: 10.1002/1096-8628(20001009)96:5<659::aid-ajmg12>3.0.co;2-g

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  11 in total

1.  Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study.

Authors:  Pushplata Prasad; Atul Ambekar; Meera Vaswani
Journal:  BMC Med Genet       Date:  2010-02-11       Impact factor: 2.103

Review 2.  Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment.

Authors:  Sarah W Yip; Marc N Potenza
Journal:  Clin Psychol Rev       Date:  2016-11-09

3.  The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems.

Authors:  Jacquelyn L Meyers; Emma Nyman; Anu Loukola; Richard J Rose; Jaakko Kaprio; Danielle M Dick
Journal:  Addict Biol       Date:  2012-09-12       Impact factor: 4.280

Review 4.  Utility of genetically modified mice for understanding the neurobiology of substance use disorders.

Authors:  Christie D Fowler; Paul J Kenny
Journal:  Hum Genet       Date:  2011-12-22       Impact factor: 4.132

5.  The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study.

Authors:  Mindi A Styn; Tomoko Nukui; Marjorie Romkes; Kenneth Perkins; Stephanie R Land; Joel L Weissfeld
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-03-05       Impact factor: 3.568

6.  Assessment of association between the dopamine D2 receptor (DRD2) polymorphism and neurodevelopment of children exposed to lead.

Authors:  Lian Liu; Xijin Xu; Taofeek Akangbe Yekeen; Kun Lin; Weiqiu Li; Xia Huo
Journal:  Environ Sci Pollut Res Int       Date:  2014-01-28       Impact factor: 4.223

Review 7.  Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?

Authors:  F Scott Hall; Jana Drgonova; Siddharth Jain; George R Uhl
Journal:  Pharmacol Ther       Date:  2013-07-18       Impact factor: 12.310

8.  Between- and within-family association test of the dopamine receptor D2 TaqIA polymorphism and alcohol abuse and dependence in a general population sample of adults.

Authors:  Brett C Haberstick; David Timberlake; Andrew Smolen; Joseph T Sakai; Christian J Hopfer; Robin P Corley; Susan E Young; Michael C Stallings; David Huizinga; Scott Menard; Christy Hartman; Jennifer Grotpeter; John K Hewitt
Journal:  J Stud Alcohol Drugs       Date:  2007-05       Impact factor: 2.582

9.  Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia.

Authors:  Laura R Lander; Vincent Setola; Shane W Kaski; Stephan Brooks; Sijin Wen; Marc W Haut; David P Siderovski; James H Berry
Journal:  J Opioid Manag       Date:  2019 Mar-Apr

Review 10.  The dopamine system and alcohol dependence.

Authors:  Hui Ma; Gang Zhu
Journal:  Shanghai Arch Psychiatry       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.